While this happened, Ladenburg Thalmann initiated its Aptevo Therapeutics Inc [APVO] rating to a Buy in a research note published recently.
Price Performance Review of APVO
On Monday, Aptevo Therapeutics Inc [NASDAQ:APVO] saw its stock fall -12.09% to $0.44. Over the last five days, the stock has lost -28.10%. Aptevo Therapeutics Inc shares have fallen nearly -89.79% since the year began. Nevertheless, the stocks have fallen -98.76% over the past one year. While a 52-week high of $44.03 was reached on 01/07/25, a 52-week low of $0.45 was recorded on 05/05/25. SMA at 50 days reached $1.7417, while 200 days put it at $7.0703.
Levels Of Support And Resistance For APVO Stock
The 24-hour chart illustrates a support level at 0.4191, which if violated will result in even more drops to 0.3983. On the upside, there is a resistance level at 0.4645. A further resistance level may holdings at 0.4891. The Relative Strength Index (RSI) on the 14-day chart is 26.51, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.1843, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 98.14%. Stochastics %K at 2.87% indicates the stock is a buying.
How much short interest is there in Aptevo Therapeutics Inc?
A steep rise in short interest was recorded in Aptevo Therapeutics Inc stocks on 2025-04-15, growing by 0.58 million shares to a total of 0.7 million shares. Yahoo Finance data shows the prior-month short interest on 2025-03-14 was 0.12 million shares. There was a rise of 82.86%, which implies that there is a positive sentiment for the stock.
